{
    "clinical_study": {
        "@rank": "77222", 
        "acronym": "HX-1171", 
        "brief_summary": {
            "textblock": "This study is designed to multiple dose and dose escalation study"
        }, 
        "brief_title": "A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.", 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Single Dose\n      Escalation Study of the Safety, Tolerabiluty, and Pharmacokinetics of HX-1171 in Healthy\n      Male Subjects"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult males aged 20 to 40 years at screening.\n\n          -  Be able to comply with the requirement of the study. Subject must provide written\n             informed consent prior to study participation.\n\n        Exclusion Criteria:\n\n          -  History or presence of liver, kidney, or nervous system disease, respiratory\n             disorders, endocrinological disorders, hemato-oncologic, cardiovascular or\n             psychiatric or gastrointestinal disorders.\n\n          -  History of known hypersensitivity to drugs including HX-1171."
            }, 
            "gender": "Male", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "firstreceived_date": "June 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01889745", 
            "org_study_id": "2013_0361"
        }, 
        "intervention": {
            "arm_group_label": "Anti-oxidatnat, Anti-Inflamation", 
            "description": "Anti-oxidatant, Anti-inflamation", 
            "intervention_name": "HX-1171", 
            "intervention_type": "Drug", 
            "other_name": [
                "1-O-hexyl-2,3,5-trimethylhydroquinone", 
                "HX-1171 500mg"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 20, 2013", 
        "link": {
            "description": "Asan medical center", 
            "url": "http://ctc.amc.seoul.kr"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Special City of Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Asan Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "official_title": "A Phase I Clinical Study, Randomized, Single-blind,Placebo-controlled, Multiple Doses, Dose Escalation Study fo the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.", 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Kyun-Seop Bae, M.D., Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Temporarily not available", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01889745"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Biotoxtech Co., Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biotoxtech Co., Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "June 2013"
    }
}